• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parmax Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 6620.0
  • ISIN : INE240T01014
42.24 1 (2.00%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    41.30

  • Today’s High

    42.24

  • Open

    42.24

  • Perv Close

    41.41

  • 52W Low

    25.03

  • 52W High

    54.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    15.80

  • Div & Yield %

    0.00

  • Book Value(₹)

    -2.16

  • Debt-Equity Ratio

    2.00

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    15.80

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.74

  • BV (₹)

    -2.20

  • Sales( ₹ in Cr.)

    11.05

  • NP (in Cr.)

    -5.78

  • NP Var(%)

    -5453.0

  • Div%

    0.0

  • CPS (₹)

    -10.90

  • EPS (₹)

    -15.40

  • Traded Value (₹ in Lakhs)

    15.80

  • 52 Week High

    54.00

  • 52 Week Low

    25.03

  • Price BSE

    42.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    15.80

  • P/C Ratio

    -3.90

  • P/E Ratio

    -2.70

  • Price Vs.BV

    -15.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 11.05 15.42 18.25 26.20 20.93 12.01
Excise Duty 8.32 11.47 12.94 24.83 19.36 6.47
Net Sales 11.05 15.42 18.25 26.20 20.93 12.01
Other Income 0.05 0.04 0.06 0.09 0.10 0.05
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 11.10 15.46 18.31 26.29 21.02 12.04
EXPENDITURE :
Raw Materials 8.32 11.47 12.94 24.83 19.36 6.47
Power & Fuel Cost 8.32 11.47 12.94 24.83 19.36 6.47
Employee Cost 2.91 2.80 3.46 3.54 2.91 2.08
Other Manufacturing Expenses 0.47 0.50 0.53 0.65 0.65 0.12
Selling & Administrative Expenses 0.85 1.04 1.23 1.21 0.84 0.81
Miscellaneous Expenses 0.47 0.50 0.53 0.65 0.65 0.12
Less : Pre-operative Expenses Capitalised :
Total Expenditure 16.76 15.42 18.01 25.08 20.29 11.95
Operating Profit 3.14 3.34 3.76 3.96 3.49 2.68
Interest 0.62 0.37 0.39 0.35 0.13 0.03
Gross Profit -5.66 0.05 0.30 1.21 0.73 0.10
Depreciation 1.71 1.88 1.93 1.94 1.01 1.03
Profit Before Tax -5.66 0.05 0.30 1.21 0.73 0.10
Tax 0.00 0.19 0.23 0.30 0.15 0.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -0.04 -0.05 0.16 0.15 -0.06
Reported Net Profit -5.78 -0.10 0.14 0.75 0.43 0.08
Extraordinary Items -5.66 0.05 0.30 1.21 0.73 0.10
Adjusted Net Profit -5.78 -0.10 0.14 0.75 0.43 0.08
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.78 -0.10 0.14 0.75 0.43 0.08
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -34.73 -0.28 0.38 2.02 1.15 0.21
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    30.80%

  • Public Share Holding

    69.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,152,450 30.80 1,152,450 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,152,450 30.80 1,152,450 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 4,100 0.11 2,500 4
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,817 0.16 5,817 10
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 17,512 0.47 7,512 16
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,092,983 29.21 1,092,983 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,268,438 33.90 307,308 2,290
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 200,000 5.35 200,000 1
Sub Total 2,588,850 69.20 1,616,120 2,331
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,741,300 100.00 2,768,570 2,334

Company Background

Parmax Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Parmax Pharma Ltd
  • BSE Code : 6620.0
  • ISIN : INE240T01014

  • Incorporation Year

    1994

  • Registered Office

    Plot No 20 Survey No 52
    Tal Kotda Sangani Hadamtala, Rajkot,
    Gujarat-360311

  • Telephone

    91-2827-270534/535

  • FAX

  • Chairman

  • Managing Director

    Umang Alkesh Gosalia

  • Company Secretary

    Bhakti Rameshbhai Aghera

  • Auditor

    B A Shah S R Mehta & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Parmax Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parmax Pharma 42.24 11.10 11.05 -7.71 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92